New findings confirm the transforming potential of KSHV and pinpoint the active components of hCG used to treatKaposi's sarcoma (pages 428–440).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lee, H. et al. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nature Med. 4, 435–140 (1998).
Lunardi-lskandar, Y. et al. Effects of human chori-onic gonadotropin-associated factor on HIV-1 and on disease induced by HIV-1. Nature Med. 4, 428–434 (1998).
Duboise, S.M., Guo, J., Czajak, S., Desrosiers, C. & Jung, J.U. STP and Tip are essential for herpesvirus saimiri oncogenicity. J. Virology 72, 1308–1313 (1998).
Albini, A. et al. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1 /KDR receptor on vascular endothelial cells. Nature Med. 2, 1371–1375 (1996).
Lunardi-Iskandar, Y. et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375, 64–68 (1995).
Gill, P.S. et al. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J. Natl. Cancer Inst. 89,1979–1802 (1997).
Griffiths, S.J., Adams, D.J. & Talbot, S.J. Ribonuclease inhibits Kaposi's sarcoma. Nature 390, 568 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scadden, D. Mother knows best. Nat Med 4, 390–391 (1998). https://doi.org/10.1038/nm0498-390
Issue Date:
DOI: https://doi.org/10.1038/nm0498-390